1 May 2026Oral drugsSource update: November 2024
Hyoscine butylbromide = Butylscopolamine oral
Hyoscine butylbromide guidance for gastrointestinal and genitourinary tract spasms, with anticholinergic safety limits.
Prescription under medical supervision
This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.
Therapeutic action
Antispasmodic.
Indications
Spasms of the gastrointestinal tract and genitourinary tract.
Forms and strengths
- 10 mg tablet.
Dose
Do not exceed recommended doses, especially in children and older patients because of the risk of severe anticholinergic effects.
- Adult: 10 to 20 mg, to be repeated up to 3 or 4 times daily if necessary.
Duration
According to clinical response; no prolonged treatment.
Contra-indications, adverse effects, precautions
- Do not administer to patients with urethro-prostatic disorders, cardiac disorders, or closed-angle glaucoma.
- May cause urinary retention, dryness of the mouth, constipation, blurred vision, and tachycardia.
- Administer with caution and under close supervision to patients taking other anticholinergic drugs.
- Administer with caution to patients with fever because thermoregulation may be affected.
- Pregnancy: no contra-indication; no prolonged treatment.
- Breast-feeding: no contra-indication; no prolonged treatment.
Source
MSF Essential drugs practical guidelines (January 2026)
This page reproduces the structured reference information for this batch while leaving out the Storage and Remarks sections.
Rate this guide
Be the first to rate this guide.